Cargando…

Developing a Collaborative Study Protocol for Combining Payer-Specific Data and Clinical Trials for CER

Detalles Bibliográficos
Autores principales:	Sanchez, Robert J., Mardekian, Jack, Cziraky, Mark J., Mullins, C. Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437906/ https://www.ncbi.nlm.nih.gov/pubmed/22074673 http://dx.doi.org/10.18553/jmcp.2011.17.s9-a.S34

Ejemplares similares

Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011)

Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012)

Looking at CER from Medicare’s Perspective
por: Mohr, Penny
Publicado: (2012)

Looking at CER from the Pharmaceutical Industry Perspective
por: Dubois, Robert W.
Publicado: (2012)

Looking at CER from the Managed Care Organization Perspective
por: Cannon, H. Eric
Publicado: (2012)

Bringing Liraglutide to Market: A CER Case Study
por: Oderda, Gary, et al.
Publicado: (2012)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Infrastructure Requirements for Secondary Data Sources in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Introduction
por: Cziraky, Mark J.
Publicado: (2008)

Can CER Be an Effective Tool for Change in the Development and Assessment of New Drugs and Technologies?
por: Brixner, Diana I., et al.
Publicado: (2012)

“Ten Commandments” for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Willke, Richard J., et al.
Publicado: (2011)

Introduction
por: Mullins, C. Daniel, et al.
Publicado: (2011)

Applying Oncology Formulary and Benefit Design Innovations to the Management of Multiple Myeloma in the Managed Care Setting
por: Mullins, C. Daniel
Publicado: (2012)

Collaborative Strategies for Improving Clinical Resource Utilization: How Pharmacists Can Make a Difference
por: Rodvold, Keith A.
Publicado: (2009)

Combination Therapy
por: Denke, Margo A.
Publicado: (2003)

Evidence for Long-Term Use of Intramuscular Interferon Beta-1a: An Overview of Relapse, Disability, and MRI Data from Selected Clinical Trials
por: Foley, John F., et al.
Publicado: (2013)

The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
por: Talbert, Robert L.
Publicado: (2008)

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

Continuing Education
por: Lipsy, Robert J., et al.
Publicado: (2004)

Health Information Technology—Results From a Roundtable Discussion
por: Balfour, Donald C., et al.
Publicado: (2009)

The Future of Medicare Part D Drug Plans—Results From a Roundtable Discussion
por: Balfour III, Donald C., et al.
Publicado: (2009)

Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
por: Menzin, Joseph, et al.
Publicado: (2013)

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Successful HIV Treatment
por: Cohen, Calvin J.
Publicado: (2006)

Introduction
por: Sax, Michael J.
Publicado: (2005)

Value-Based Benefit Design: Using a Predictive Modeling Approach to Improve Compliance
por: Mahoney, John J.
Publicado: (2008)

Essential Steps and Practical Applications for Database Studies
por: Sax, Michael J.
Publicado: (2005)

Disease Progression and the Application of Evidence-Based Treatment Guidelines Diagnose It Early: A Case for Screening and Appropriate Management
por: Manley, Harold J.
Publicado: (2007)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

Introduction
por: Lipsy, Robert J.
Publicado: (2003)

Evidence Based Medicine Health Care's Next Holy War
por: Kleinke, J.D.
Publicado: (2005)

Not Getting to Goal: The Clinical Costs of Noncompliance
por: Ansell, Benjamin J.
Publicado: (2008)

Preview Overview
por: Lipsy, Robert J.
Publicado: (2004)

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
por: Scott, Shane J., et al.
Publicado: (2003)

The Importance and Impact of Evidence Based medicine
por: Lewis, Sonya J., et al.
Publicado: (2004)

Introduction
por: kleinke, J.D., et al.
Publicado: (2005)

Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013)

Continuing Education
por: Carter, Barry L., et al.
Publicado: (2004)

Continuing Education
por: Chrischilles, Elizabeth A., et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_5jvtudmvvujcogo641uh3cru9t